Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cosmos Health Inc
(NQ:
COSM
)
0.7196
-0.0404 (-5.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cosmos Health Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today?
June 28, 2024
Elicio Therapeutics stock is down on Friday after the company announced a proposed public offering for shares of ELTX this morning.
Via
InvestorPlace
Why Is Nexalin Technology (NXL) Stock Down 35% Today?
June 28, 2024
Nexalin Technology stock is down on Friday after the company announced the pricing of NXL shares in the public offering.
Via
InvestorPlace
Why Is Cosmos Health (COSM) Stock Up 65% Today?
June 28, 2024
Cosmos Health stock is up on Friday with heavy trading of COSM shares following news of a distribution agreement in the UAE.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 28, 2024
Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower!
Via
InvestorPlace
Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units
June 27, 2024
Via
ACCESSWIRE
Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent
June 18, 2024
Via
ACCESSWIRE
Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million
June 13, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
May 30, 2024
Via
Benzinga
Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q
May 24, 2024
Via
ACCESSWIRE
Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand
May 17, 2024
Via
ACCESSWIRE
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Healthcare Stocks
April 30, 2024
These are the list of healthcare stocks to avoid that present challenges indicating signs of a crash in the near future.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
April 29, 2024
Via
Benzinga
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
April 19, 2024
Via
ACCESSWIRE
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
March 21, 2024
Via
ACCESSWIRE
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
March 19, 2024
Via
ACCESSWIRE
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
March 18, 2024
Via
ACCESSWIRE
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
February 29, 2024
Via
ACCESSWIRE
Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying
February 22, 2024
The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price
February 21, 2024
Via
ACCESSWIRE
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
February 20, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 07, 2024
Via
Benzinga
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
February 01, 2024
Via
ACCESSWIRE
Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market
January 23, 2024
Via
ACCESSWIRE
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
January 18, 2024
Via
ACCESSWIRE
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
December 27, 2023
Via
ACCESSWIRE
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
December 20, 2023
Via
ACCESSWIRE
Cosmos Health Announces Open Market Stock Purchases by the CEO
December 18, 2023
Via
ACCESSWIRE
Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York
December 08, 2023
Via
ACCESSWIRE
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
December 07, 2023
Via
ACCESSWIRE
Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product
December 01, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.